Last year, I wrote a paper for one of my classes on the ethical dilemmas of mitochondrial replacement therapy. I spent nine weeks on that paper. This year, my anatomy prof. had apparently read my paper, and invited me to go with him to this year’s Nobel Conference. This year’s topic: reproductive technologies; how far should we go? It was great to hear all the different perspectives on human genome technologies, (google CRISPR-Cas9 if you want more information) but there was one phrase that a woman ,who worked as an IVF technician in the United Kingdom, used that troubled me. “We must alleviate the burden of choice from parents in regards to treatment of genetic illness.” At what point does “alleviating the burden of choice,” waltz into “removing the freedom of choice” from the parents of these children? I’m sure “alleviating the burden of choice,” really worked out well for Charlie Gard’s parents.